Home
Ra Capital Management reported a 9.9% stake in C4 Therapeutics CCCC · 9,441,256 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9.9%
- Last report
- 0% · filed 25/05/15
- Shares held
- 9,441,256 sh
- Class
- Common Stock, $0.0001 par value per share
- Stock
- C4 Therapeutics CCCC
- Holder
- Ra Capital Management
- Event date
- 25/10/17
- Filed
- 25/10/24
9.9% stake · +9.9pp from the last report
- Stake
- 9.9%
- Last report
- 0%
- Since last report
- +9.9pp
C4 Therapeutics trades, last 26 weeks
What else happened in C4 Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/17~25/11/16Ra Capital Management's other 5% stake reports
- Ra Capital Management
5% stakeCorbus Pharmaceuticals Holdings
5% stakeCorbus Pharmaceuticals Holdings
CRBP
9.9% stake
1,914,788 sh
9.9% stake
Filed 09/30
- Ra Capital Management
5% stakeBetterLife Pharma
5% stakeBetterLife Pharma
BETRF
9% stake
55,420,000 sh
9% stake
Filed 09/22
- Ra Capital Management
5% stakeSionna Therapeutics
5% stakeSionna Therapeutics
SION
14.3% stake
6,476,193 sh
14.3% stake
Filed 09/21
- Ra Capital Management
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
19.9% stake
14,130,492 sh
19.9% stake
Filed 09/17
- Ra Capital Management
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.1% stake
450,000 sh
5.1% stake
Filed 09/03
